423 related articles for article (PubMed ID: 27212034)
1. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype.
Yu J; Liang Q; Wang J; Wang K; Gao J; Zhang J; Zeng Y; Chiu PW; Ng EK; Sung JJ
Oncogene; 2017 Jan; 36(2):182-193. PubMed ID: 27212034
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide identification of Epstein-Barr virus-driven promoter methylation profiles of human genes in gastric cancer cells.
Zhao J; Liang Q; Cheung KF; Kang W; Lung RW; Tong JH; To KF; Sung JJ; Yu J
Cancer; 2013 Jan; 119(2):304-12. PubMed ID: 22833454
[TBL] [Abstract][Full Text] [Related]
3. Somatostatin receptor 1, a novel EBV-associated CpG hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer.
Zhao J; Liang Q; Cheung KF; Kang W; Dong Y; Lung RW; Tong JH; To KF; Sung JJ; Yu J
Br J Cancer; 2013 Jun; 108(12):2557-64. PubMed ID: 23722468
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic inactivation of paired box gene 5, a novel tumor suppressor gene, through direct upregulation of p53 is associated with prognosis in gastric cancer patients.
Li X; Cheung KF; Ma X; Tian L; Zhao J; Go MY; Shen B; Cheng AS; Ying J; Tao Q; Sung JJ; Kung HF; Yu J
Oncogene; 2012 Jul; 31(29):3419-30. PubMed ID: 22105368
[TBL] [Abstract][Full Text] [Related]
5. Integrative identification of Epstein-Barr virus-associated mutations and epigenetic alterations in gastric cancer.
Liang Q; Yao X; Tang S; Zhang J; Yau TO; Li X; Tang CM; Kang W; Lung RW; Li JW; Chan TF; Xing R; Lu Y; Lo KW; Wong N; To KF; Yu C; Chan FK; Sung JJ; Yu J
Gastroenterology; 2014 Dec; 147(6):1350-62.e4. PubMed ID: 25173755
[TBL] [Abstract][Full Text] [Related]
6. Ras association domain family member 10 suppresses gastric cancer growth by cooperating with GSTP1 to regulate JNK/c-Jun/AP-1 pathway.
Li X; Liang Q; Liu W; Zhang N; Xu L; Zhang X; Zhang J; Sung JJ; Yu J
Oncogene; 2016 May; 35(19):2453-64. PubMed ID: 26279301
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of WNT5A in Epstein-Barr virus-associated gastric carcinoma.
Liu X; Wang Y; Wang X; Sun Z; Li L; Tao Q; Luo B
Arch Virol; 2013 Jan; 158(1):123-32. PubMed ID: 23001722
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic inactivation of BCL6B, a novel functional tumour suppressor for gastric cancer, is associated with poor survival.
Xu L; Li X; Chu ES; Zhao G; Go MY; Tao Q; Jin H; Zeng Z; Sung JJ; Yu J
Gut; 2012 Jul; 61(7):977-85. PubMed ID: 21917650
[TBL] [Abstract][Full Text] [Related]
9. Tumor cell-expressed IL-15Rα drives antagonistic effects on the progression and immune control of gastric cancer and is epigenetically regulated in EBV-positive gastric cancer.
Wei J; Guo C; An X; Miao W; Zhang C; Wang B; Cai W; Li M; Zhang F
Cell Oncol (Dordr); 2020 Dec; 43(6):1085-1097. PubMed ID: 32767257
[TBL] [Abstract][Full Text] [Related]
10. ARID1A deficiency in EBV-positive gastric cancer is partially regulated by EBV-encoded miRNAs, but not by DNA promotor hypermethylation.
Kase K; Saito M; Nakajima S; Takayanagi D; Saito K; Yamada L; Ashizawa M; Nakano H; Hanayama H; Onozawa H; Okayama H; Endo H; Fujita S; Sakamoto W; Saze Z; Momma T; Mimura K; Ohki S; Shiraishi K; Kohno T; Kono K
Carcinogenesis; 2021 Feb; 42(1):21-30. PubMed ID: 33196828
[TBL] [Abstract][Full Text] [Related]
11. Activation of EHF via STAT3 phosphorylation by LMP2A in Epstein-Barr virus-positive gastric cancer.
Li W; Okabe A; Usui G; Fukuyo M; Matsusaka K; Rahmutulla B; Mano Y; Hoshii T; Funata S; Hiura N; Fukayama M; Tan P; Ushiku T; Kaneda A
Cancer Sci; 2021 Aug; 112(8):3349-3362. PubMed ID: 34014591
[TBL] [Abstract][Full Text] [Related]
12. Aberrant gene promoter methylation of p16, FHIT, CRBP1, WWOX, and DLC-1 in Epstein-Barr virus-associated gastric carcinomas.
He D; Zhang YW; Zhang NN; Zhou L; Chen JN; Jiang Y; Shao CK
Med Oncol; 2015 Apr; 32(4):92. PubMed ID: 25720522
[TBL] [Abstract][Full Text] [Related]
13. p73 gene promoter methylation in Epstein-Barr virus-associated gastric carcinoma.
Ushiku T; Chong JM; Uozaki H; Hino R; Chang MS; Sudo M; Rani BR; Sakuma K; Nagai H; Fukayama M
Int J Cancer; 2007 Jan; 120(1):60-6. PubMed ID: 17058198
[TBL] [Abstract][Full Text] [Related]
14. Epstein-barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma.
Kang GH; Lee S; Kim WH; Lee HW; Kim JC; Rhyu MG; Ro JY
Am J Pathol; 2002 Mar; 160(3):787-94. PubMed ID: 11891177
[TBL] [Abstract][Full Text] [Related]
15. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
16. Activation of DNA methyltransferase 1 by EBV latent membrane protein 2A leads to promoter hypermethylation of PTEN gene in gastric carcinoma.
Hino R; Uozaki H; Murakami N; Ushiku T; Shinozaki A; Ishikawa S; Morikawa T; Nakaya T; Sakatani T; Takada K; Fukayama M
Cancer Res; 2009 Apr; 69(7):2766-74. PubMed ID: 19339266
[TBL] [Abstract][Full Text] [Related]
17. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes.
Matsusaka K; Kaneda A; Nagae G; Ushiku T; Kikuchi Y; Hino R; Uozaki H; Seto Y; Takada K; Aburatani H; Fukayama M
Cancer Res; 2011 Dec; 71(23):7187-97. PubMed ID: 21990320
[TBL] [Abstract][Full Text] [Related]
18. Zinc-finger protein 331, a novel putative tumor suppressor, suppresses growth and invasiveness of gastric cancer.
Yu J; Liang QY; Wang J; Cheng Y; Wang S; Poon TC; Go MY; Tao Q; Chang Z; Sung JJ
Oncogene; 2013 Jan; 32(3):307-17. PubMed ID: 22370639
[TBL] [Abstract][Full Text] [Related]
19. Methylation and expression of Epstein-Barr virus latent membrane protein 1, 2A and 2B in EBV-associated gastric carcinomas and cell lines.
Li J; Liu X; Liu M; Che K; Luo B
Dig Liver Dis; 2016 Jun; 48(6):673-80. PubMed ID: 27026080
[TBL] [Abstract][Full Text] [Related]
20. KCNMA1 cooperating with PTK2 is a novel tumor suppressor in gastric cancer and is associated with disease outcome.
Ma G; Liu H; Hua Q; Wang M; Du M; Lin Y; Ge Y; Gong W; Zhao Q; Qiang F; Tao G; Zhang Z; Chu H
Mol Cancer; 2017 Feb; 16(1):46. PubMed ID: 28231797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]